COVID Vaccines: Johnson & Johnson Supply Issues Won't Impact Oakland Coliseum Site
COVID Vaccines: Johnson & Johnson Supply Issues Won't Impact Oakland Coliseum Site

An obstacle in vaccinating America as roughly 15 million doses of the Johnson and Johnson vaccine at a manufacturing site have been tossed out.

Despite the announcement, the Oakland Coliseum vaccination said it will switch to the J&J vaccine Thursday.

Andrea Nakano reports.

(3/31/21)